Atrial Arrhythmia

Cardiovascular
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Rhythm Pharmaceuticals
1 program
LINQ/LINQ IIN/A1 trial
Active Trials
NCT05488470Completed22Est. Jul 2024
DS
Daiichi SankyoChina - Shanghai
1 program
Preventicus heartbeat app in combination with wearablesN/A1 trial
Active Trials
NCT04579159Completed882Est. Feb 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rhythm PharmaceuticalsLINQ/LINQ II
Daiichi SankyoPreventicus heartbeat app in combination with wearables

Clinical Trials (2)

Total enrollment: 904 patients across 2 trials

NCT05488470Rhythm PharmaceuticalsLINQ/LINQ II

QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)

Start: Feb 2023Est. completion: Jul 202422 patients
N/ACompleted
NCT04579159Daiichi SankyoPreventicus heartbeat app in combination with wearables

The Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study (Smart in OAC - AFNET 9)

Start: Jan 2021Est. completion: Feb 2022882 patients
N/ACompleted

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
23h ago
From $150K/yr

Physician Program Director, Los Angeles

Johnson & Johnson
Danvers, Massachusetts, United States of America
Yesterday
$132K - $212K/yr

J&J MedTech Neurovascular Senior Financial Analyst, R&D

Johnson & Johnson
Irvine, California, United States of America
Yesterday
$79K - $128K/yr

Ingénieur d'Application Clinique (H/F) Dept. 54, 57, 67, 68, 25, 90

Johnson & Johnson
Issy-les-Moulineaux, France
Yesterday

Trainee Technical Specialist

Johnson & Johnson
Leeds, West Yorkshire, United Kingdom
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Heart Failure(334)Hypertension(333)Coronary Artery Disease(295)Atrial Fibrillation(288)Pulmonary Arterial Hypertension(103)Acute Coronary Syndrome(62)Pulmonary Hypertension(55)Essential Hypertension(32)Coronary Heart Disease(28)Aortic Valve Stenosis(27)